Tedizolid
ATC Code
J01XX11
Tedizolid
Definition
An antibacterial agent of the oxazolidinone class, that is used for the treatment of acute bacterial skin and skin structure infections caused by certain Gram-positive microorganisms. Upon intravenous administration, tedizolid targets and binds to the 50S subunit of the bacterial ribosome. This inhibits bacterial protein synthesis.
Also known as (5R)-3-(3-Fluoro-4-(6-(2-Methyl-2H-Tetrazol-5-yl)Pyridin-3-yl)Phenyl)-5-(Hydroxymethyl)Oxazolidin-2-One, 2-Oxazolidinone, 3-(3-Fluoro-4-(6-(2-Methyl-2H-Tetrazol-5-yl)-3-Pyridinyl)Phenyl)-5-(Hydroxymethyl)-, (5R)-, TEDIZOLID, Torezolid, TR-700 — per NCIT
Also identified as
- ATC J01XX11 per RXNORM
- NCIT NCIT:C84222 per NCIT
- SCTID 703912007 per RXNORM
- SCTID 703914008 per RXNORM
- UNII 97HLQ82NGL per RXNORM
Indications
| Disease | Relation | Source |
|---|---|---|
| Skin disease caused by bacterial infection | may treat | MEDRT · Public domain (U.S. Government work) |
| Staphylococcal infection | may treat | MEDRT · Public domain (U.S. Government work) |
| Streptococcal infection | may treat | MEDRT · Public domain (U.S. Government work) |